📣 Join us for a free public webinar on 30 April, 18:00–19:00 BST!
Hear the latest updates from the STRAVINSKY study, exploring COVID 19 risk in people with weakened immune systems. It’s free to attend with an open Q&A
Register now: vist.ly/4yunx
Measuring immune function in the wild is key to understanding resilience and disease. New open‑access research presents a practical immune toolkit for wild ungulates, revealing variation across individuals, populations and landscapes in bighorn sheep.
vist.ly/4z6gk
How Streptococcus pneumoniae interacts with innate immunity matters. New open‑access research shows neuraminidase A (NanA) shapes immune sensing and phagocytic clearance in microglia and macrophages, with implications for pneumococcal meningitis.
vist.ly/4y22j
Sounds like a great meeting
Treg therapies could restore immune tolerance, but key barriers remain. #ImmuneTherapies26
This session explores challenges including specificity and cell trafficking and how next generation approaches aim to overcome them.
Register now: vist.ly/4ynds
Vaccines protect against some of the most serious diseases we know. But their impact goes beyond infection.
Research suggests they may also support long-term health, including reducing cardiovascular risk.
Explore our latest #CelebrateVaccines blog! ➡️ vist.ly/4yngv
📢 Call for submissions: Cancer Vaccines – Global Advances
We invite research, reviews, clinical studies, commentaries & TrialsWatch articles on personalised and off‑the‑shelf cancer vaccines.
Submit by the end of April 2026
#callforpapers
📢 Calling all translational and clinical immunology researchers! We welcome high‑quality studies with the potential to transform understanding of human disease or change clinical practice.
Learn more about submitting: vist.ly/4ymyd
Severe periodontitis reflects complex immune–microbiota interactions, especially in patients with immune dysregulation. This open‑access review explores how immunology‑informed, targeted therapies could complement conventional dental treatment.
vist.ly/4yh95
Last chance to register for #UKimmunomet26!
Join us in Newcastle next week for two days of immunometabolism research, with leading speakers & dedicated Bright Sparks sessions showcasing ECRs.
📍 Hilton Newcastle Gateshead
📅 16–17 April
Register here: vist.ly/4xvny
💉 Did you take part in our #CelebrateVaccines campaign? If you’re passionate about public engagement and immunology, consider applying for Public Engagement Secretary.
UK‑based | 4‑year term | BSI members
⏰ Nominations close Thursday 16 April
vist.ly/4ycuw
Open‑access review shows how immunotherapy has transformed advanced melanoma treatment, with many patients now likely cured, and highlights emerging options for those who don’t respond to current therapies.
vist.ly/4yczq
Open‑access review explores how targeting monocyte dynamics could offer new therapeutic approaches for multiple sclerosis, with insights from experimental models highlighting monocyte plasticity and inflammation resolution.
vist.ly/4ydua
New open‑access paper outlines how the UK Vaccine Innovation Pathway is accelerating cancer vaccine trials across the NHS, boosting recruitment, streamlining delivery, and supporting equitable access.
vist.ly/4x25i
Most flow cytometry problems start before you even press “run”.
Our course on 11 & 18 May with Derek Davies focuses on panel design, real immunology examples & fixing issues you’re actually facing.
Feel free to BYOD (bring your own data)! Fully online + 30% off for BSI members.
Our new blog explores how vaccination programmes evolve, focusing on the introduction of the MMRV vaccine #CelebrateVaccines
In 1988, combining 3 vaccines into 1 helped drive UK uptake above 90%. Now, MMRV builds on this progress...
Read more 👉 vist.ly/4xr7h
⏰ One week to go!
Nominations for the 2026 BSI committees close 16 April, 12:00 GMT.
Get involved and help shape the future of immunology.
Learn more: vist.ly/4xund
Neutrophil extracellular traps (NETs) are emerging as both biomarkers and drivers of rheumatoid arthritis, linked to disease activity, treatment response and key pathogenic pathways. Targeting NET formation could open new therapeutic avenues in RA.
vist.ly/4xrct
Developing immune therapies for rare diseases: big challenges, but real opportunity! #ImmuneTherapies26
From trial design to reimbursement, this parallel session explores how to bring new treatments to smaller patient populations.
Register today: vist.ly/4xpjw
1 week left to submit your abstract for our immunosenescence meeting! ⌛
Join experts at this event in Guildford on immune ageing, from mechanisms to next generation technologies #ImmuneAgeing26
Submit now and share your work, ECRs especially encouraged: vist.ly/4xp8q
Want to understand how vaccines actually work? #WorldHealthDay #StandWithScience 🔬
Our guides explain how vaccines work with the immune system to help prevent disease, supporting informed, confident decisions.
Click here to explore our guides: vist.ly/4xjxt
Is AI more hype than hope in drug development? #ImmuneTherapies26
At the BSI ITS taking place in May, this workshop will explore the practical challenges of applying AI and where it is already making a real impact.
Register now by clicking here: vist.ly/4wxfn
IFNγ from activated CD4⁺ T cells plays a key role in driving lupus by promoting B‑cell differentiation and autoantibody production. Mice lacking IFNγ showed reduced symptoms, highlighting these cells as a potential therapeutic target.
vist.ly/4wxes
#Immunology #SLE #LupusResearch
Wild mice show large, robust T‑cell receptor repertoires that stay broad across age and sex, while older mice develop more dominant clones, likely from lifelong pathogen exposure. A fascinating look at how immunity adapts in natural environments.
vist.ly/4wxid
New research shows that adding CD28 signalling motifs to the CD3ζ chain boosts IL‑2 production and expansion of TCR‑engineered T cells, without reducing cytotoxicity. A promising step toward stronger TCR therapies for solid tumours.
Read here: vist.ly/4wxea
#Immunotherapy #TCells
How does the environment influence immunity? 🌍
Join us on 11 Sept in London for an event with @london-immuno.bsky.social to explore how microbes, diet, pollution & stress affect immune responses in health & disease #LIG26
Register early for a discount! vist.ly/4w2je
Did you know there are over 140 autoimmune diseases?
This #AutoimmuneAwarenessMonth, we’re helping spread the word and bring support to those affected, and those researching for cures.
For more info, visit autoimmune.org
This is going to be a great meeting, wish I was going to be there.
Some of my amazing BSI colleagues will be there so reach out and say hi
New study shows the Systemic Immune‑Inflammation Index (SIII) is linked to survival in patients on immune checkpoint inhibitors, with lower SIII predicting better outcomes.
Read here: vist.ly/4wedi
#Immunotherapy #CancerResearch